KHẢO SÁT NGUY CƠ TIM MẠCH TRONG 10 NĂM THEO THANG ĐIỂM ASCVD Ở BỆNH NHÂN GÚT

Abstract

Objectives: (1) To evaluate the 10-year cardiovascular risk using the ASCVD score in patients with gout. (2) To investigate the association between cardiovascular risk and certain clinical and paraclinical characteristics of the study group.Subjects and Methods: A cross-sectional descriptive study was conducted on 156 patients diagnosed with gout according to the 2015 ACR/EULAR criteria, who attended examination and treatment at Bach Mai Hospital from November 2024 to September 2025. Clinical information (age, sex, disease duration, BMI, gout type, presence of tophi, hypertension, diabetes, smoking) and paraclinical data (uric acid, hs-CRP, blood lipids, glucose) were collected. The 10-year cardiovascular risk was calculated using the ASCVD (Atherosclerotic Cardiovascular Disease Risk Score). Results: The mean age was 56.68 ± 8.94 years, with 66.7% aged ≥ 50 years. The mean disease duration was 4.51 ± 2.91 years; chronic gout accounted for 42.3%, overweight/obesity 56.4%, hypertension 52.6%, dyslipidemia 75.6%, diabetes 13.5%, and smoking 53.2%. The mean ASCVD score was 14.86 ± 10.68%. Risk stratification: low–borderline 35.9%, intermediate 37.8%, high 26.3%. ASCVD risk increased significantly in patients aged ≥ 50 years, disease duration ≥ 5 years, chronic gout, presence of tophi, hypertension, and diabetes, with corresponding values of 15.35; 10.19; 2.94; 13.75; and 3.46 (P < 0.01). Conclusions: Among gout patients, 42.1% had intermediate–high ASCVD cardiovascular risk. Older age, longer disease duration, chronic gout, hypertension, diabetes, smoking, and hyperuricemia contributed to increased risk.